NCT00417820View on ClinicalTrials.gov

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

November 30, 2007

Conditions
Psoriasis
Interventions
DRUG

BCT194

Trial Locations (1)

Unknown

Novartis Investigative Site, Vienna

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY